Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Acute Ischemic Stroke Management, Cerebrovascular and Carotid Artery Diseases, Antiplatelet Therapy and Cardiovascular Diseases, and Coronary Interventions and Diagnostics.
Intra-arterial Tenecteplase for Acute Stroke After Successful Endovascular Therapy
Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke
Targeting formyl peptide receptor 1 reduces brain inflammation and neurodegeneration
Cadmium isotopic evidence for the redistribution and fate of cadmium during carbonate weathering
Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trial
Colchicine in patients with acute ischaemic stroke or transient ischaemic attack (CHANCE-3): multicentre, double blind, randomised, placebo controlled trial
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia
Brain lesion characteristics in Chinese multiple sclerosis patients: A <scp>7‐T MRI</scp> cohort study
Chinese Stroke Association guidelines on emergency stroke unit
The development of the neurocritical care specialty in China based on the analysis of neurocritical care unit volume and quality
Trial of Endovascular Therapy for Acute Ischemic Stroke with Large Infarct
Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke
The STROMICS genome study: deep whole-genome sequencing and analysis of 10K Chinese patients with ischemic stroke reveal complex genetic and phenotypic interplay
Pyrotinib and chrysin synergistically potentiate autophagy in HER2-positive breast cancer
Indobufen versus aspirin in patients with acute ischaemic stroke in China (INSURE): a randomised, double-blind, double-dummy, active control, non-inferiority trial
One-year direct and indirect costs of ischaemic stroke in China
The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
Ticagrelor versus Clopidogrel in <i>CYP2C19</i> Loss-of-Function Carriers with Stroke or TIA
Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial
Metabolomics analysis of cucumber fruit in response to foliar fertilizer and pesticides using UHPLC-Q-Orbitrap-HRMS
A parallel attention‐augmented bilinear network for early magnetic resonance imaging‐based diagnosis of Alzheimer's disease
Dynamics and risk assessment of pesticides in cucumber through field experiments and model simulation
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
Association of Polyvascular Disease and Elevated Interleukin-6 With Outcomes in Acute Ischemic Stroke or Transient Ischemic Attack
China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations
Identifying cultural heritage corridors for preservation through multidimensional network connectivity analysis — a case study of the ancient Tea-Horse Road in Simao, China
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
Neutrophil counts, neutrophil ratio, and new stroke in minor ischemic stroke or TIA
Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns